Abstract:Objective: To investigate the clinical variables that might predict the outcome of developmental and epileptic encephalopathy (DEE) after vagus nerve stimulation (VNS) therapy and identify the risk factors for poor long-term outcome. Patients and methods: We retrospectively studied 32 consecutive children with drug-resistant DEE who had undergone VNS surgery from April 2019 to July 2021, which were not suitable for corpus callosotomy. In spite of combining valproic acid, levetiracetam, lamotrigine, topiramate, etc. (standard anti-seizure medicine available in China) it has not been possible to effectively reduce seizures in the population we investigate (Cannabidiol and brivaracetam were not available in China). A responder was defined as a frequency reduction decrease > 50%. Seizure freedom was defined as freedom from seizures for at least 6 months. Sex, electroencephalograph (EEG) group, neurodevelopment, time lag, gene mutation, magnetic resonance imaging (MRI), and epilepsy syndrome were analyzed with Fisher's exact test, The age at onset and age at VNS therapy were analyzed with Kruskal-Wallis test, statistical significance was defined as p < 0.05. And used the effect size to correction. Results: Among the 32 patients, the median age at VNS implantation was 4.7 years (range: 1–12 years). At the most recent follow-up, five children (15.6%) were seizure-free and 22 (68.8%) were responders. Univariate analysis demonstrated that the responders were significantly associated with mild development delay/intellectual disability ( p = 0.044; phi coefficient = 0.357) and a multifocal EEG pattern ( p = 0.022; phi coefficient = −0.405). Kaplan-Meier survival analyses demonstrated that a multifocal EEG pattern ( p = 0.049) and DEE without epileptic spasm (ES) ( p = 0.012) were statistically significant ( p = 0.030). Multivariate analysis demonstrated that DEE with ES had significant predictive value for poor long-term outcome ( p = 0.014, hazard ratio = 5.433, confidence interval = 1.402–21.058). Conclusions: Our study suggested that VNS was a generally effective adjunct treatment for DEE. Although the predictive factors for VNS efficacy remain unclear, it should be emphasized that patients with ES are not suitable candidates for epilepsy surgery. Further investigations are needed to validate the present results.

Vagus nerve stimulation for refractory posttraumatic epilepsy: Efficacy and predictors of seizure outcome

Vagus nerve stimulation for pediatric patients with intractable epilepsy between 3 and 6 years of age: study protocol for a double-blind, randomized control trial

Efficacy and Potential Predictors of Vagus Nerve Stimulation Therapy in Refractory Postencephalitic Epilepsy.

Vagus Nerve Stimulation Therapy For The Treatment Of Seizures In Refractory Postencephalitic Epilepsy: A Retrospective Study

A Prediction Model Integrating Synchronization Biomarkers and Clinical Features to Identify Responders to Vagus Nerve Stimulation among Pediatric Patients with Drug-Resistant Epilepsy.

Effectiveness of vagus nerve stimulation therapy in refractory hypoxic-ischemic encephalopathy-induced epilepsy

Vagus nerve stimulation for pharmacoresistant epilepsy secondary to encephalomalacia: A single-center retrospective study

Can we predict response to vagus nerve stimulation in intractable epilepsy

Vagus nerve stimulation for drug-resistant epilepsy induced by tuberous sclerosis complex

Long-term outcomes and prognosis factors of vagus nerve stimulation in patients with refractory epilepsy

Long-term Effect of Vagus Nerve Stimulation on Interictal Epileptiform Discharges in Refractory Epilepsy

Vagus nerve stimulation for treating developmental and epileptic encephalopathy in young children

Vagus nerve stimulation for patients with refractory epilepsy: Demographic features and neuropsychological outcomes of the VNS Taiwan child neurology society database

Long-term effects of vagus nerve stimulation on EEG aperiodic components in patients with drug-resistant epilepsy

Efficacy of Vagal Nerve Stimulation for Pharmacoresistant Poststroke Epilepsy

Epilepsy duration as an independent predictor of response to vagus nerve stimulation

Vagus nerve stimulation for the treatment of refractory epilepsy

Brain functional connectivity and network characteristics changes after vagus nerve stimulation in patients with refractory epilepsy

Predictors of Seizure Reduction Outcome after Vagus Nerve Stimulation in Drug-Resistant Epilepsy

Vagus nerve stimulation for epilepsy: A narrative review of factors predictive of response

Efficacy analysis of vagus nerve stimulation for the treatment of drug resistant epilepsy: A report of 110 cases